Joint pain in menopause: what is true, what is false

You wake up stiff. Your knees protest on the stairs. Your shoulder no longer rises quite the way it used to. And when you mention it, you generally get one of two answers: "it's your age", or "it's in your head". Both answers are wrong, and the second one hurts.

Joint pain is among the most common complaints of perimenopause, and among the least taken seriously. Since 2024, a term has been circulating widely on social media to name it: the "musculoskeletal syndrome of menopause". It puts an apt word on a real experience. You still need to know what the term is worth scientifically, what hormones really explain, what hormone therapy changes and, above all, when you should not attribute your pain to menopause.

Is it common? What the cohorts show

The short answer is yes. A longitudinal study published in the journal Pain in 2024 followed 609 women through the different stages of menopause. The frequency and intensity of muscle and joint pain increased as women advanced through the transition, and the end of perimenopause stood out as a pivotal moment: the one when this pain most often appears^[1].

This result has to be read for what it is. It is an observational study: it establishes that two things go together over time, not that one causes the other. It was carried out in an urban Chinese population, which rules out transposing precise percentages from it. But it confirms an essential point: the timing matches. If you have the impression that everything went out of order at the same time, you are not wrong. In that same study, weight, anxiety and mood were closely associated with pain intensity, without it being possible to say what drives what.

The essential counterpoint: « it is not just menopause »

This is the most important point in this article, and it goes against a great deal of online content. The large American cohort on women's health in midlife, the SWAN study, followed more than 3,000 women for sixteen years. The researchers gave their paper a title that is a warning in itself: "It is not just menopause"^[2].

What they show is twofold. First, the pain almost never comes alone: it forms a block with fatigue, sleep problems and hot flashes. Second (and this is the most counterintuitive part), these symptom profiles were already present before menopause, and stayed fairly stable over time: depending on the group, 39 to 76% of women kept the same profile as they moved through the stages.

In other words: not everything begins on the day of your last period. Blaming absolutely everything on menopause is the surest way to miss something else, and we will see below what that "something else" can be.

A UK Biobank analysis covering nearly 95,000 women points in a similar direction: a later menopause was associated with a slightly lower burden of chronic pain years later. The measured effect is real but modest: on the order of a few percent per year of age at menopause^[3]. A lead, not an explanation.

The « musculoskeletal syndrome of menopause »: what the term is worth

You may have seen it go by. It comes from a paper published in 2024 in the journal Climacteric by a team led by orthopedic surgeon Vonda Wright^[4]. The idea is to group under a single name things that until then were handled separately: joint pain, loss of muscle mass, loss of bone density, progression of osteoarthritis. The authors put forward that more than 70% of women would experience musculoskeletal symptoms during the transition, and that about one in four would be genuinely disabled by them.

The success of this term is understandable, and it is legitimate: it finally puts a word on a real experience, long sent back to women as a vague complaint. But we have to be precise about its status.

This paper is what is called a narrative review: a reasoned synthesis, not a prevalence study. It is the weakest level of evidence in the scientific hierarchy. The authors themselves write, in black and white, "we introduce a new term". This syndrome is recognized by no medical classification, has no validated diagnostic criteria, and no learned society has adopted it to date.

Practical consequence: keep the figure of 70% as an order of magnitude, not as an established fact. And if you arrive at your doctor's office talking about this syndrome, it is possible that they will never have heard of it, and they will not be wrong.

Does estrogen really play a role?

There is a solid argument, and it comes from somewhere other than menopause. Aromatase inhibitors, prescribed after a hormone-dependent breast cancer, deliberately collapse estrogen levels. A meta-analysis of 21 studies covering more than 13,000 women finds that about 46% of them develop joint pain, with a confidence interval running from 40 to 52%^[6]. It is a kind of natural experiment: you lower estrogen, and the joints hurt.

Two cautions, however. Heterogeneity between studies was maximal (individual rates run from 20 to 74%), so 46% is an aggregate order of magnitude. And above all, this is a sudden and artificial hormonal drop, in women often treated with chemotherapy: this figure does not transpose to natural menopause. A review devoted to this syndrome stresses moreover that estrogen deprivation would act both on musculoskeletal tissue and on the nervous system (so also on the way pain is perceived), but that the exact mechanism remains poorly understood^[7].

And hormones do not explain everything. A review published in Osteoarthritis and Cartilage in 2024 recalls a frankly counterintuitive fact: the differences between girls' and boys' knees (cartilage, meniscus, cruciate ligament) are already visible in childhood, and these differences "are not explained by sex hormones alone"^[12]. That same review recalls that osteoarthritis is not simple wear of the cartilage, but a disease of the whole joint.

On the precise mechanism in women, let us stay cautious: we know that these tissues carry sex hormone receptors, and the hypothesis is that the drop in estrogen changes how they work. This mechanism is not demonstrated. It is a serious lead, not a closed explanation.

Does hormone therapy relieve joint pain?

A little, and much less than is claimed. Here we have the best possible data: a randomized placebo-controlled trial, the Women's Health Initiative, on 10,739 postmenopausal women who had had a hysterectomy and received estrogen alone^[5].

At the start, about 77% of participants had joint pain, in both groups. After one year: 76.3% of women with pain in the estrogen group, versus 79.2% on placebo. The difference is statistically real and holds up to the third year. But look at the figures: we are talking about roughly three percentage points. The authors themselves use the word "modest".

And there is a flip side it would be dishonest to leave out: joint swelling was slightly more frequent on estrogen (42.1% versus 39.7%).

What can honestly be said, then: hormone therapy slightly reduces the frequency of reported joint pain. What absolutely cannot be said: that it treats osteoarthritis. No imaging, no cartilage was measured in this study, only symptoms reported by questionnaire. Joint relief is not an indication for hormone therapy, and hormone therapy remains a personalized medical decision, to be taken with the professional who knows your file.

A word about frozen shoulder (adhesive capsulitis), which is much discussed: it typically affects women between 40 and 60, which has obviously made people think of hormones. A 2026 pilot study compared nearly 2,000 women and found 7.65% of adhesive capsulitis in those without hormone therapy versus 3.95% in the others, but the difference was not statistically significant^[13]. It is a lead, not a result. Worth noting: diabetes and thyroid disorders, for their part, are well established risk factors for adhesive capsulitis.

What really works, and how much

The answer is a little frustrating, and it is very solid: movement.

A 2024 Cochrane review brought together 139 randomized trials and more than 12,000 participants on knee osteoarthritis. Exercise improves pain, function and quality of life: on a scale from 0 to 100, about 13 points better on pain compared with doing nothing^[8]. Let us be frank, as the authors are: the certainty of the evidence is judged low to moderate, the benefit is demonstrated in the short term, and its clinical importance remains uncertain. It remains, by far, the best documented, cheapest and least risky intervention available.

Which exercise? A network meta-analysis published in the BMJ in 2025, on 217 trials and nearly 16,000 participants, puts endurance exercise first for pain, with strength training and mixed programmes standing out above all on function in the medium term^[9]. These are largely indirect comparisons: read them as a probable ranking, not as an established hierarchy. In practice, the best exercise remains the one you will do regularly.

Second lever: weight. A randomized trial published in JAMA in 2022, on 823 people of whom more than three quarters were women, compared a diet plus exercise programme with simple follow-up. Result: 7.7 kg lost versus 1.7 kg. On knee pain, the improvement was statistically significant but below the threshold considered clinically important^[10]. In other words: it helps, it does not cure. Also worth noting in that trial: a few injuries, strains and falls, mostly in the active group. Exercise is not without risk and progression must be gradual.

Supplements: what the science really says

This is the point that will disappoint a few readers. A meta-analysis published in the British Journal of Sports Medicine examined 20 supplements across 69 studies^[11].

On glucosamine and chondroitin (the best sellers), the authors' conclusion is unambiguous: they were "either ineffective, or with small effects that are arguably of no clinical importance".

Turmeric, curcumin and hydrolysed collagen do show short-term effects, sometimes of substantial size. But the effect and the level of evidence have to be cited in the same sentence: the authors judge the overall quality of the evidence "very low", and no supplement retains a clinically important effect in the medium or long term.

Two further limits are worth knowing. These data are about osteoarthritis, not specifically about menopausal arthralgia, for which there is no quality data. And small supplement studies are particularly exposed to publication bias and to industry funding.

If you take them and they suit you, they do no harm. But do not build your strategy on that, and do not pay a lot for it. As for "anti-inflammatory diets" presented as a solution to menopausal pain: no solid data allows that claim. You can eat a balanced diet for a thousand good reasons, but not by promising an effect on the joints.

When it is not menopause: the signals not to miss

Not all joint pain after 45 is menopause. Certain signals deserve medical advice:

• morning stiffness that lasts well beyond a few minutes;
• a joint that swells or becomes warm;
• pain in the shoulders and pelvis after 50, with stiffness;
• general signs: fever, night sweats, unexplained weight loss;
• a shoulder that gradually loses its mobility, including when someone else tries to move it;
• pain that wakes you at night and worsens despite movement.

Two diagnoses matter particularly here. Polymyalgia rheumatica affects people over 50 and produces pain and stiffness in the shoulders and pelvis; blood markers of inflammation are usually raised in it, which is not the case in menopausal arthralgia. There is no single test: the diagnosis is medical work by elimination^[14]. Rheumatoid arthritis, for its part, is an inflammatory autoimmune disease that affects the joints and the soft tissue around them^[15].

Remember a phrase rheumatologists use: the "window of opportunity". Diagnosed and treated early, these diseases are controlled far better today: a growing number of patients reach remission. Diagnosed late, that chance is lost.

None of these signs means you have something serious: most pain at this age has ordinary explanations. But it is reason enough to talk to your doctor rather than wait.

What to remember

Your pain is real, it increases across the transition, and the end of perimenopause is a pivotal moment. It never comes alone: it goes with sleep, mood and fatigue. The "musculoskeletal syndrome of menopause" puts an apt word on your experience, but it is not yet a validated diagnosis. Estrogen plays a role (the aromatase inhibitor example shows it), but it does not explain everything. Hormone therapy slightly reduces reported pain, on the order of three percentage points, and it does not treat osteoarthritis. Movement remains your best lever, and supplements do not keep their promises.

And above all: with a swollen joint or prolonged morning stiffness, you see a doctor. That is not alarmism, it is exactly the opposite: it is what makes it possible not to miss the rare situations where time matters.

Frequently asked questions

Does menopause hormone therapy relieve joint pain?

A little, and much less than is claimed. In a randomized placebo-controlled trial covering 10,739 postmenopausal women, 76.3% of women on estrogen reported joint pain after one year, versus 79.2% on placebo. The difference is real and holds up to the third year, but it represents about three percentage points: the authors themselves call it "modest". Joint swelling was moreover slightly more frequent on estrogen. Joint relief is not an indication for hormone therapy, which remains a personalized medical decision.

Is the "musculoskeletal syndrome of menopause" a real diagnosis?

Not to date. The term was proposed in 2024 in the journal Climacteric by a team led by orthopedic surgeon Vonda Wright, who explicitly writes "we introduce a new term". It is a narrative review (the weakest level of evidence) and not a prevalence study. This syndrome is recognized by no medical classification, has no validated diagnostic criteria, and no learned society has adopted it. The figure of "more than 70% of women" relayed on social media is an estimate by the authors.

Do collagen, turmeric or glucosamine really help?

The best available synthesis, a meta-analysis of 69 studies covering 20 supplements, concludes that glucosamine and chondroitin were "either ineffective, or with small effects that are arguably of no clinical importance". Turmeric and hydrolysed collagen show short-term effects, but the authors judge the overall quality of the evidence "very low", and no supplement retains a clinically important effect in the medium or long term. These data are moreover about osteoarthritis, not about menopausal arthralgia.

Which exercise should you choose when it already hurts?

The one you will do regularly. But if you are looking for a starting point, endurance exercise has the best credentials. A 2024 Cochrane review (139 randomized trials, more than 12,000 participants) shows that exercise improves pain, function and quality of life, with low to moderate certainty of evidence and a short-term benefit. A 2025 BMJ meta-analysis puts aerobic exercise first for pain, with strengthening standing out on function. Progression must be gradual: the JAMA trial reported a few injuries and falls in the active group.

When should you see a doctor rather than attribute your pain to menopause?

With morning stiffness that lasts well beyond a few minutes, a joint that swells or becomes warm, pain in the shoulders and pelvis after 50, general signs (fever, night sweats, unexplained weight loss), a shoulder that gradually loses its mobility, or pain that wakes you at night and worsens despite movement. None of these signs means there is something serious, but in inflammatory diseases rheumatologists speak of a "window of opportunity": diagnosed early, they are controlled far better.

⚠️ This article is provided for informational and educational purposes only. It does not replace medical advice, diagnosis or treatment. Always consult your doctor or a qualified health professional with any questions about your health.

How we work: our editorial method · Written and verified by Bouchra, editorial lead.

How we work: our editorial method · Written and verified by Bouchra, editorial lead.